Please login to the form below

Not currently logged in
Email:
Password:

Sutimlimab

This page shows the latest Sutimlimab news and features for those working in and with pharma, biotech and healthcare.

FDA issues approval for Sanofi’s Enjaymo treatment for patients with CAD

FDA issues approval for Sanofi’s Enjaymo treatment for patients with CAD

The US FDA has approved Sanofi’s Enjaymo (sutimlimab-jome) for the treatment of adults diagnosed with the rare blood disorder, cold agglutinin disease (CAD).

Latest news

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
11 London

We live in a hyper-connected world. This has clear benefits for the health of our communities, our businesses and our...

Latest intelligence

Box 1
Strategic commitment
...
KOL Ambassador Program & Podcast Creation: A Customer Story
...
Animation: Living With
The journey from the patient's perspective...